Biogen Inc (BIIB)
194.44
+3.99
(+2.10%)
USD |
NASDAQ |
Apr 19, 16:00
194.44
0.00 (0.00%)
After-Hours: 20:00
Biogen Accounts Payable (Quarterly): 403.30M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 403.30M |
September 30, 2023 | 440.10M |
June 30, 2023 | 445.40M |
March 31, 2023 | 491.20M |
December 31, 2022 | 491.50M |
September 30, 2022 | 383.20M |
June 30, 2022 | 434.80M |
March 31, 2022 | 398.70M |
December 31, 2021 | 589.20M |
September 30, 2021 | 427.90M |
June 30, 2021 | 375.30M |
March 31, 2021 | 430.40M |
December 31, 2020 | 454.90M |
September 30, 2020 | 398.40M |
June 30, 2020 | 383.90M |
March 31, 2020 | 389.00M |
December 31, 2019 | 530.80M |
September 30, 2019 | 382.20M |
June 30, 2019 | 377.10M |
March 31, 2019 | 378.00M |
December 31, 2018 | 370.50M |
September 30, 2018 | 342.30M |
June 30, 2018 | 295.70M |
March 31, 2018 | 345.80M |
December 31, 2017 | 395.50M |
Date | Value |
---|---|
September 30, 2017 | 298.70M |
June 30, 2017 | 330.30M |
March 31, 2017 | 316.40M |
December 31, 2016 | 279.80M |
September 30, 2016 | 274.00M |
June 30, 2016 | 225.90M |
March 31, 2016 | 271.30M |
December 31, 2015 | 267.40M |
September 30, 2015 | 251.23M |
June 30, 2015 | 282.70M |
March 31, 2015 | 236.13M |
December 31, 2014 | 229.20M |
September 30, 2014 | 233.63M |
June 30, 2014 | 224.93M |
March 31, 2014 | 212.81M |
December 31, 2013 | 219.91M |
September 30, 2013 | 166.71M |
June 30, 2013 | 163.09M |
March 31, 2013 | 165.21M |
December 31, 2012 | 204.00M |
September 30, 2012 | 157.42M |
June 30, 2012 | 159.15M |
March 31, 2012 | 173.33M |
December 31, 2011 | 186.45M |
September 30, 2011 | 159.20M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
375.30M
Minimum
Jun 2021
589.20M
Maximum
Dec 2021
433.02M
Average
427.90M
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
Eli Lilly and Co | 2.599B |
Bristol-Myers Squibb Co | 3.259B |
AbbVie Inc | 3.688B |
Amgen Inc | 1.59B |
Regeneron Pharmaceuticals Inc | 606.60M |